Evidence map›Paper›PMID 31994261›Full record

ArticleProtein science : a publication of the Protein Society2020

Establishing Trypanosoma cruzi farnesyl pyrophosphate synthase as a viable target for biosensor driven fragment-based lead discovery.

Giulia Opassi, Helena Nordström, Arne Lundin, Valeria Napolitano, Francesca Magari, Tom Dzus, Gerhard Klebe, U Helena Danielson

Open access · hybridAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Giulia OpassiDepartment of Chemistry-BMC, Uppsala University, Uppsala, Sweden.
Helena NordströmDepartment of Chemistry-BMC, Uppsala University, Uppsala, Sweden.
Arne LundinBioThema, Handen, Sweden.
Valeria NapolitanoMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Francesca MagariInstitut für Pharmazeutische Chemie, Phillips-Universität Marburg, Marburg, Germany.
Tom DzusDepartment of Chemistry-BMC, Uppsala University, Uppsala, Sweden.
Gerhard KlebeInstitut für Pharmazeutische Chemie, Phillips-Universität Marburg, Marburg, Germany.ORCID 0000-0003-0177-537X
U Helena DanielsonDepartment of Chemistry-BMC, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-2728-0340
Uppsala University · SEPhilipps University of Marburg · DEHansa Biopharma (Sweden) · SEJagiellonian University · PL

Funding

Marie Curie 675555 Accelerated Early staGe drug discovery
6 · The paper itself

Abstract

Procedures for producing and exploring Trypanosoma cruzi farnesyl pyrophosphate synthase (tcFPPS) for surface plasmon resonance (SPR) biosensor-driven fragment-based discovery have been established. The method requires functional sensor surfaces with high sensitivity for extended times and appropriate controls. Initial problems with protein stability and lack of useful reference compounds motivated optimization of experimental procedures and conditions. The improved methods enabled the production of pure, folded and dimeric protein, and identified procedures for storage and handling. A new coupled enzymatic assay, using luciferase for detection of pyrophosphate, was developed and used to confirm that the purified enzyme was active after purification and storage. It also confirmed that sensor surfaces prepared with structurally intact protein was active. An SPR-biosensor assay for fragment library screening and hit confirmation was developed. A thermal shift assay was used in parallel. A library of 90 fragments was efficiently screened by both assays at a single concentration in the presence and absence of the catalytic cofactor Mg

Indexed as

CatalysisGeranyltranstransferaseMagnesiumSurface Plasmon ResonanceTrypanosoma cruziGeranyltranstransferaseMagnesiumbinding efficiencyChagas diseasefarnesyl pyrophosphate synthasefragment screeningSPRTrypanosoma cruzi

Identifiers

PMID31994261
PMCPMC7096706
OpenAlexW3004225905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.